Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer

被引:0
|
作者
Li, Kunlin [1 ]
Li, Lin [1 ]
Xie, Xiyue [1 ]
Zhu, Jing [1 ]
Xia, Daqing [1 ]
Xiang, Lunli [1 ]
Cai, Kaiyong [1 ]
Zhang, Jixi [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, 174 Shazheng St, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor immunotherapy; Responsive self-assembly; Photoacoustic effects; Lysosomal membrane permeabilization; Endoplasmic reticulum stress; THERAPY;
D O I
10.1016/j.actbio.2024.08.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although immunogenic cell death (ICD) induced by lysosomal membrane permeabilization (LMP) evidently enhance the effectiveness of antitumor immunity for triple-negative breast cancer (TNBC) with poor immunogenicity, their potential is increasingly restricted by the development of other death pathways and the repair of lysosomes by endoplasmic reticulum (ER) during LMP induction. Herein, a poly- dopamine nanocomposite with i-motif DNA modified and BNN6 loaded is prepared toward boosting LMP and immunotherapy of TNBC by synergy of spatially confined photoacoustic (PA) effects and nitric oxide. Combining the high-frequency pulsed laser (40 0 0 kHz) with the intra-lysosomal assembly of nanocomposites produced spatially confined and significantly boosted PA effects (4.8-fold higher than the individually dispersed particles extracellular), suppressing damage to other cellular components and selectively reducing lysosomal integrity to 19.2 %. Simultaneously, the releasing of nitric oxide inhibited the repair of lysosomes by ER stress, causing exacerbated LMP. Consequently, efficient immune activation was achieved, including the abundant releasing of CRT/HMGB1 (5.93-6.8-fold), the increasing maturation of dendritic cells (3.41-fold), and the fostered recruitment of CD4+/CD8+ T cells (3.99-3.78-fold) in vivo . The study paves a new avenue for the rational design and synergy of confined energy conversion and responsive nanostructures to achieve the treatment of low immunogenicity tumors.
引用
收藏
页码:381 / 395
页数:15
相关论文
共 50 条
  • [11] Clinical trials of immunotherapy in triple-negative breast cancer
    Frederick M. Howard
    Alexander T. Pearson
    Rita Nanda
    Breast Cancer Research and Treatment, 2022, 195 : 1 - 15
  • [12] Clinical trials of immunotherapy in triple-negative breast cancer
    Howard, Frederick M.
    Pearson, Alexander T.
    Nanda, Rita
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (01) : 1 - 15
  • [13] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [14] Immunotherapy in Triple-Negative Breast Cancer: Present and Future
    Kim, Isaac
    Sanchez, Katherine
    McArthur, Heather L.
    Page, David
    CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 259 - 271
  • [15] Updates on the preoperative immunotherapy for triple-negative breast cancer
    Hu, Hong
    Kaklamani, Virginia
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [16] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [17] Present and Future of Immunotherapy for Triple-Negative Breast Cancer
    Sriramulu, Sushmitha
    Thoidingjam, Shivani
    Speers, Corey
    Nyati, Shyam
    CANCERS, 2024, 16 (19)
  • [18] Progress and challenges of immunotherapy in triple-negative breast cancer
    Zhu, Yinxing
    Zhu, Xuedan
    Tang, Cuiju
    Guan, Xiaoxiang
    Zhang, Wenwen
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [19] Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
    Wesolowski, Jakub
    Tankiewicz-Kwedlo, Anna
    Pawlak, Dariusz
    CANCERS, 2022, 14 (16)
  • [20] Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
    Luo, Chenyi
    Wang, Peipei
    He, Siqi
    Zhu, Jingjing
    Shi, Yuanyuan
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2022, 12